How are experts navigating subcutaneous therapy administrations in multiple myeloma? Beth Faiman, PhD, MSN, APN-BC, AOCN, FAAN, FAPO, and Sikander Ailawadhi, MD, break down newer patient-centric approaches #mmsm #oncology

Listen now: www.onclive.com/view/navigat...

🗞️ Just in: The phase 3 EXCALIBER-RRMM trial met its second dual primary end point, with iberdomide plus daratumumab/dexamethasone extending PFS vs DVd in patients with R/R multiple myeloma #mmsm #oncology

Read more: www.onclive.com/view/iberdom...

A real-world study from @moffittnews.bsky.social showed talquetamab produced similar response rates in patients with relapsed/refractory multiple myeloma, irrespective of whether they met the eligibility criteria for MonumenTAL-1 #mmsm #oncology

Read more: www.onclive.com/view/talquet...

👀 NXC-201, a sterically optimized BCMA-directed CAR T-cell therapy, produced a high response rates in R/R AL amyloidosis, according to an interim update from the phase 1b/2 NEXICART-2 trial.

Full details 📰: www.onclive.com/view/nxc-201...

#oncology #mmsm

We're LIVE today at 7pm ET with myeloma specialist Dr. Douglas Sborov! Get ready to ask him all your myeloma questions as we close out #BloodCancerAwarenessMonth. Click "Going" on Facebook & turn on notifications to RSVP: https://www.facebook.com/events/1388778123259596/

#KnowMyeloma #mmsm

📣 ESHLYMPHOMA2026 PROGRAMME HIGHLIGHT:
SESSION 6 "Hodgkin lymphoma"
5th How to Diagnose and Treat Lymphoma
October 29-31, 2026 / Prague, Czech Republic
Chairs: Christian Buske, Michael Crump, Gilles Salles, Catherine Thieblemont
More info ➡ bit.ly/42eJ3s6
#ESHCONFERENCES #Haematology #MMsm #Lmsm

In treating R/R #MMsm, BCMA-targeted CAR-T therapy prior to a bispecific antibody led to greater OS rates (79% vs. 63%) than did a bispecific antibody followed by CAR-T therapy, suggesting that such a sequencing strategy could improve survival probability: https://ow.ly/Q2X450ZRwY3

How can older myeloma patients decide what treatment is still worth pursuing? IMF NLB member Sam Shenoy answers and points to the IMF's free Decision-Making Tool at myeloma.org.

#AsktheIMF #KnowMyeloma #mmsm

The EMA's CHMP offered a positive opinion recommending the approval of teclistamab for the treatment of adult patients with R/R multiple myeloma who have received at least 1 prior therapy #mmsm #oncology

Read more: www.onclive.com/view/chmp-re...

CHMP of the EMA issued a positive opinion supporting melflufen plus dexamethasone for the treatment of multiple myeloma after at least 2 prior lines of therapy that is refractory to lenalidomide and to the last line of therapy. #mmsm #oncology
www.onclive.com/view/chmp-re...

The latest version of the NCCN Guidelines for multiple myeloma include a dedicated section on MRD assessments with recommendations for clinical practice. Dive into the latest MRD updates and updated treatment recommendations #mmsm #oncology www.onclive.com/view/updated...

It's #BloodCancerAwarenessMonth!
No one piece of evidence can uncover myeloma. Doctors look at abnormal blood tests, lab numbers, imaging scans, and other specialty tests to diagnose it. Tell us: How did you or your team figure out you had myeloma?

#KnowMyeloma #mmsm

By 2034, 1 in 4 people diagnosed with myeloma will be African American. Knowing the early signs can be the key to timely diagnosis. Learn the symptoms to look for at knowmyeloma.org

#BloodCancerAwarenessMonth #mmsm #KnowMyeloma

📣 DISCOVER THE LEARNING OBJECTIVES OF #ESHCART2027
4th How I Manage CAR-T Therapies & Bispecific Antibodies for my Patients
Sept. 24-26, 2027|Stockholm, Sweden
Chairs: Michael Hudecek, Caron Jacobson, Marie José Kersten
For more information ➡ bit.ly/4ckiDZT
#ESHCONFERENCES #HAEMATOLOGY #MMsm #Lmsm

📣 PROGRAMME HIGHLIGHT OF #ESHLYMPHOMA2026
3 simultaneous Meet-the-Expert sessions
5th How to Diagnose and Treat Lymphoma
October 29-31, 2026 / Prague, Czech Republic
Chairs: Christian Buske, Michael Crump, Gilles Salles, Catherine Thieblemont
More info ➡ bit.ly/42eJ3s6
#ESHCONFERENCES #MMsm #Lmsm

It’s an honor to be captain of Team @roswellpark.bsky.social and a Board of Trustee for @bloodcancerunited.bsky.social
I need your help raising $ for patients, families and critical research for blood cancer. These pennies still matter! #lymsm #mmsm #leusm #bmtsm
pages.lls.org/ltn/wcny/Buf...

2️⃣ conferences at once! Get ready for #SOHO2026 in Houston and #WCLC26 in Seoul!
🤠 Over the next few days, we’ll be covering the two conferences in-depth with expert insight all on our site! 🇰🇷
@societyofhemonc.bsky.social @iaslc.bsky.social #lcsm #leusm #mmsm #mpnsm #lymsm #oncology #hematology

Just in 📰: The GPRC5D-directed CAR T-cell therapy arlo-cel met the primary ORR end point of the phase 2 QUINTESSENTIAL trial in patients with quadruple-class exposed, relapsed/refractory multiple myeloma #mmsm #oncology

Read more: www.onclive.com/view/arlo-ce...